Image1_Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic.PNG (7.22 kB)
Download fileImage1_Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease.PNG
figure
posted on 2022-01-24, 04:46 authored by Li-Min Zhao, Ze-Lin Zhan, Jie Ning, Mei QiuThe full text of this article can be freely accessed on the publisher's website.
History
References
- https://doi.org//10.1161/JAHA.119.014908
- https://doi.org//10.1056/NEJMoa2025845
- https://doi.org//10.1056/NEJMoa2030186
- https://doi.org//10.2337/dci19-0066
- https://doi.org//10.1093/ehjcvp/pvab034
- https://doi.org//10.1056/NEJMoa2004967
- https://doi.org//10.1111/dom.14601
- https://doi.org//10.1161/CIRCULATIONAHA.120.051901
- https://doi.org//10.1016/j.cct.2006.04.004
- https://doi.org//10.1161/CIRCULATIONAHA.120.051898
- https://doi.org//10.1186/s12933-019-0899-9
- https://doi.org//10.1136/bmj.d5928
- https://doi.org//10.7326/M14-2385
- https://doi.org//10.1159/000516213
- https://doi.org//10.1161/CIRCULATIONAHA.119.042007
- https://doi.org//10.1056/NEJMoa1611925
- https://doi.org//10.1161/CIRCULATIONAHA.118.035901
- https://doi.org//10.1056/NEJMoa1811744
- https://doi.org//10.1007/s12020-020-02359-5
- https://doi.org//10.2174/1389450119666180531102227
- https://doi.org//10.1053/j.ajkd.2021.02.324
- https://doi.org//10.1016/j.biopha.2021.111918
- https://doi.org//10.1056/NEJMoa1515920
- https://doi.org//10.1161/CIRCULATIONAHA.117.028268
- https://doi.org//10.1016/s2213-8587(20)30369-7
- https://doi.org//10.1056/NEJMoa1812389
- https://doi.org//10.1002/ehf2.13313
- https://doi.org//10.1016/j.jstrokecerebrovasdis.2021.105799
- https://doi.org//10.3389/fcvm.2021.679124
- https://doi.org//10.1056/NEJMoa1504720
